Cystic Fibrosis: Detecting Changes in Airway Inflammation with FDG PET/CT
Authors:
- Reshma AminRAReshma Amin
- Martin CharronMCMartin Charron
- Leonard GrinblatLGLeonard Grinblat
- Amer ShammasASAmer Shammas
- Hartmut GrasemannHGHartmut Grasemann
- Karla GranielKGKarla Graniel
- Pierluigi CietPierluigi Ciet
- Harm TiddensHTHarm Tiddens
- Felix RatjenFRFelix Ratjen
- 1 September 2012
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 264 (3) , 868-875
Abstract
Fluorine 18 fluorodeoxyglucose PET/CT imaging can help quantify and localize pulmonary inflammation in cystic fibrosis (CF) and track clinical improvement in pediatric patients with CF who are admitted to the hospital with pulmonary exacerbations before and after intravenous antibiotic therapy. PurposeTo determine if fluorine 18 fluorodeoxyglucose (FDG) positron emission tomographic (PET)/computed tomographic (CT) imaging can depict a treatment effect from intravenous antibiotics for pulmonary exacerbation in cystic fibrosis (CF).Materials and MethodsThe study was approved by the institutional review board of the Hospital for Sick Children and by Health Canada. Consent was obtained from all subjects. Patients with CF who were between 6 and 18 years of age and were admitted for a pulmonary exacerbation were eligible for the study. FDG PET/CT examinations (with low-dose CT) were performed on days 1 and 14 of admission (±72 hours). PET activity was quantified by using standardized uptake values (SUVs) through assessment of background activity (mean SUV [SUVmean]) and superimposed focal uptake (maximum SUV [SUVmax]) for each lung zone. CT studies were scored by using the CF-CT model. SUVs from pre- and posttherapy studies were compared by using paired t tests. Unpaired t tests were used to compare d...Keywords
This publication has 41 references indexed in Scilit:
- Safety of bronchoalveolar lavage in young children with cystic fibrosisPediatric Pulmonology, 2008
- Airway Inflammation in Cystic FibrosisChest, 2008
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Imaging Pulmonary Inflammation with Positron Emission Tomography: A Biomarker for Drug DevelopmentMolecular Pharmaceutics, 2006
- Improving rate of decline of FEV1 in young adults with cystic fibrosisThorax, 2006
- Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Uptake of18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?European Respiratory Journal, 2003
- Early airway infection, inflammation, and lung function in cystic fibrosisArchives of Disease in Childhood, 2002
- Inflammation, Infection, and Pulmonary Function in Infants and Young Children with Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Current understanding of the inflammatory process in cystic fibrosis: Onset and etiologyPediatric Pulmonology, 1997